How much dividend does BioArctic pay?
Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.67 %. For the coming 12 months, BioArctic is expected to pay a dividend of 0 SEK.
BioArctic Dividend 2024
BioArctic Dividend
0 SEK
BioArctic Dividend yield
0.67 %
Ticker
BIOA B.ST
ISIN
SE0010323311
WKN
A2H5GS
How much dividend does BioArctic 2024 pay?
According to the latest status from July 2024, BioArctic paid a total of 0 SEK per share in dividends within the last 12 months. With the current BioArctic price of 224.8 SEK, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| 0.67 % Dividend Yield | = |
|
Historical BioArctic Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 6/10/2019 | 1.5 |
1
BioArctic Stock Dividend SE0010323311 · A2H5GS
In 2023, BioArctic paid a dividend amounting to 0 SEK. Dividend means that BioArctic distributes a portion of its profits to its owners.
3 years
5 years
10 years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for BioArctic provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify BioArctic’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating BioArctic's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
BioArctic Dividend History
| Date | BioArctic Dividend |
|---|---|
| 2019 | 1.5 SEK |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2015 | 0 SEK | 0 SEK |
| 2016 | 0 SEK | 0 SEK |
| 2017 | 0 SEK | 0 SEK |
| 2018 | 0 SEK | 0 SEK |
| 2019 | 1.5 SEK | 0 SEK |
| 2020 | 0 SEK | 0 SEK |
| 2021 | 0 SEK | 0 SEK |
| 2022 | 0 SEK | 0 SEK |
| 2023 | 0 SEK | 0 SEK |
| 2024e | 0 SEK | 0 SEK |
| 2025e | 0 SEK | 0 SEK |
| 2026e | 0 SEK | 0 SEK |
| 2027e | 0 SEK | 0 SEK |
| 2028e | 0 SEK | 0 SEK |
Is the BioArctic Dividend Safe?
BioArctic has been increasing the dividend for 1 years.
Over the past 9 years, BioArctic has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
BioArctic Stock Payout Ratio SE0010323311 · A2H5GS
In 2023, BioArctic had a payout ratio of 149.31%. The payout ratio indicates the percentage of the company's profits that BioArctic distributes as dividends.
3 years
5 years
10 years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for BioArctic represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for BioArctic could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate BioArctic's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
BioArctic Payout Ratio History
| Date | BioArctic Payout ratio |
|---|---|
| 2028e | 149.31 % |
| 2027e | 149.31 % |
| 2026e | 149.31 % |
| 2025e | 149.31 % |
| 2024e | 149.31 % |
| 2023 | 149.31 % |
| 2022 | 149.31 % |
| 2021 | 149.31 % |
| 2020 | 149.31 % |
| 2019 | 149.31 % |
| 2018 | 149.31 % |
| 2017 | 149.31 % |
| 2016 | 149.31 % |
| 2015 | 149.31 % |
| Payout ratio | |
|---|---|
| 2015 | 149.31 % |
| 2016 | 149.31 % |
| 2017 | 149.31 % |
| 2018 | 149.31 % |
| 2019 | 149.31 % |
| 2020 | 149.31 % |
| 2021 | 149.31 % |
| 2022 | 149.31 % |
| 2023 | 149.31 % |
| 2024e | 149.31 % |
| 2025e | 149.31 % |
| 2026e | 149.31 % |
| 2027e | 149.31 % |
| 2028e | 149.31 % |
Dividend Details
Understanding BioArctic's Dividend Distributions
BioArctic’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining BioArctic's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
BioArctic's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in BioArctic’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
BioArctic Aktienanalyse
What does BioArctic do?
BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about BioArctic stock
What is the dividend yield of BioArctic?
The current dividend yield of BioArctic is 0.67 %.
When does BioArctic pay dividends?
BioArctic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioArctic?
BioArctic paid dividends every year for the past 5 years.
What is the dividend of BioArctic?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioArctic located?
BioArctic is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.
When did BioArctic pay the last dividend?
The last dividend was paid out on 5/16/2019.
What was the dividend of BioArctic in the year 2023?
In the year 2023, BioArctic distributed 0 SEK as dividends.
In which currency does BioArctic pay out the dividend?
The dividends of BioArctic are distributed in SEK.
Andere Kennzahlen von BioArctic
Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
